Is early-life iron exposure critical in neurodegeneration?

Nature Reviews Neurology

Volumn 11, Issue 9, 2015, Pages 536-544

  Hare, Dominic J ^a   Arora, Manish ^b   Jenkins, Nicole L ^c   Finkelstein, David I ^c   Doble, Philip A ^a   Bush, Ashley I ^c  

^a UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IRON; LACTOFERRIN; TRANSFERRIN; TRANSFERRIN RECEPTOR 2;

ALZHEIMER DISEASE; ANALYTICAL PARAMETERS; ANEMIA; ARTIFICIAL MILK; BLOOD BRAIN BARRIER; BRAIN DEVELOPMENT; BREAST FEEDING; CHEMICAL COMPOSITION; CHILD DEVELOPMENT; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; EVIDENCE BASED MEDICINE; FOOD COMPOSITION; HEMOCHROMATOSIS; HUMAN; INFANT NUTRITION; IRON ABSORPTION; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON TEETH LEVEL; IRON THERAPY; LOW BIRTH WEIGHT; NEURODEGENERATION WITH BRAIN IRON ACCUMULATION; NEUROIMAGING; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PERINATAL DRUG EXPOSURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROCESS OPTIMIZATION; RETROSPECTIVE STUDY; REVIEW; SUBSTANTIA NIGRA PARS COMPACTA; AGING; ANIMAL; BRAIN; GROWTH, DEVELOPMENT AND AGING; METABOLISM;

AGING; ALZHEIMER DISEASE; ANIMALS; BRAIN; HUMANS; IRON; PARKINSON DISEASE;

EID: 84941022712     PISSN: 17594758     EISSN: 17594766     Source Type: Journal    
DOI: 10.1038/nrneurol.2015.100     Document Type: Review

References (147)

1. Beard, J. L. Iron biology in immune function, muscle metabolism and neuronal functioning. J. Nutr. 131, 568S-579S (2001
2. Weinberg, E. D. The Lactobacillus anomaly: total iron abstinence. Perspect. Biol. Med. 40, 578-583 (1997
3. Aguirre, J. D. et al. A manganese-rich environment supports superoxide dismutase activity in a Lyme disease pathogen, Borrelia burgdorferi. J. Biol. Chem. 288, 8468-8478 (2013
4. Beard, J. L., Connor, J. R. & Jones, B. C. Iron in the brain. Nutr. Rev. 51, 157-170 (1993
5. Beard, J. Iron deficiency alters brain development and functioning. J. Nutr. 133, 1468S-1472S (2003
6. Ziegler, E. E., Nelson, S. E. & Jeter, J. M. Iron supplementation of breastfed infants from an early age. Am. J. Clin. Nutr. 89, 525-532 (2009
7. Lozoff, B. & Georgieff, M. K. Iron deficiency and brain development. Semin. Pediatr. Neurol. 13, 158-165 (2006
8. Carter, R. C. et al. Iron deficiency anemia and cognitive function in infancy. Pediatrics 126, e427-e434 (2010
9. World Health Organization. Worldwide prevalence of anaemia 1993-2005: WHO global database on anaemia. World Health Organization Institutional Repository for Information Sharing [online], http://whqlibdoc.who.int/publications/2008/9789241596657-eng.pdf (2008).
10. Zimmermann, M. B. & Hurrell, R. F. Nutritional iron deficiency. Lancet 370, 511-520 (2007
11. Horta, B., Victora, C. & World Health Organization. Long-term effects of breastfeeding: A systematic review. World Health Organization Institutional Repository for Information Sharing [online]. http://apps.who.int/iris/bitstream/10665/79198/1/9789241505307-eng.pdf?ua=1 (2013
12. Ibanez, G. et al. Prevalence of breastfeeding in industrialized countries. Rev. Epidemiol. Sante Publique 60, 305-320 (2012
13. Kong, S. K. & Lee, D. T. Factors influencing decision to breastfeed. J. Adv. Nurs. 46, 369-379 (2004
14. Obladen, M. Historic records on the commercial production of infant formula. Neonatology 106, 173-180 (2014
15. Forsyth, S. Non-compliance with the International Code of Marketing of Breast Milk Substitutes is not confined to the infant formula industry. J. Public Health (Oxf.) 35, 185-190 (2013
16. Lucas, A. et al. Efficacy and safety of long-chain polyunsaturated fatty acid supplementation of infant-formula milk: A randomised trial. Lancet 354, 1948-1954 (1999
17. Saarinen, U. M. Need for iron supplementation in infants on prolonged breast feeding. J. Pediatr. 93, 177-180 (1978
18. Siimes, M. A., Salmenperä, L. & Perheentupa, J. Exclusive breast-feeding for 9 months: risk of iron deficiency. J. Pediatr. 104, 196-199 (1984
19. Lowe, C. U. et al. Iron balance and requirements in infancy. Pediatrics 43, 134-142 (1969
20. McMillan, J. A., Landaw, S. A. & Oski, F. A. Iron sufficiency in breast-fed infants and the availability of iron from human milk. Pediatrics 58, 686-691 (1976
21. [No authors listed] American Academy of Pediatrics Committee on Nutrition: Iron-fortified infant formulas. Pediatrics 84, 1114-1115 (1989
22. [No authors listed] Iron fortification of infant formulas. American Academy of Pediatrics. Committee on Nutrition. Pediatrics 104, 119-123 (1999
23. Baker, R. D., Greer, F. R. & Committee on Nutrition American Academy of Pediatrics. Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0-3 years of age). Pediatrics 126, 1040-1050 (2010
24. Koletzko, B. et al. Global standard for the composition of infant formula: recommendations of an ESPGHAN coordinated international expert group. J. Pediatr. Gastroenterol. Nutr. 41, 584-599 (2005
25. Domellöf, M. et al. Iron requirements of infants and toddlers. J. Pediatr. Gastroenterol. Nutr. 58, 119-129 (2014
26. MacLean, W. C. Jr et al. Upper levels of nutrients in infant formulas: comparison of analytical data with the revised Codex infant formula standard. J. Food Comp. Anal. 23, 44-53 (2010
27. Singhal, A. et al. Clinical safety of iron-fortified formulas. Pediatrics 105, E38 (2000
28. Sachdev, H., Gera, T. & Nestel, P. Effect of iron supplementation on mental and motor development in children: systematic review of randomised controlled trials. Public Health Nutr. 8, 117-132 (2005
29. Friel, J. K. et al. A double-masked, randomized control trial of iron supplementation in early infancy in healthy term breast-fed infants. J. Pediatr. 143, 582-586 (2003
30. Berglund, S., Westrup, B. & Domellöf, M. Iron supplements reduce the risk of iron deficiency anemia in marginally low birth weight infants. Pediatrics 126, e874-e883 (2010
31. Lozoff, B., Castillo, M., Clark, K. M. & Smith, J. B. Iron-fortified vs low-iron infant formula: developmental outcome at 10 years. Arch. Pediatr. Adolesc. Med. 166, 208-215 (2012
32. Hernell, O. & Lönnerdal, B. Recommendations on iron questioned. Pediatrics 127, e1099-e1101 (2011
33. Furman, L. M. Exclusively breastfed infants: iron recommendations are premature. Pediatrics 127, e1098-e1099 (2011
34. AAP Section on Breastfeeding et al. Concerns with early universal iron supplementation of breastfeeding infants. Pediatrics 127, e1097 (2011
35. De La Flor St Remy, R. R., Sánchez, M. L., Sastre, J. B. & Sanz-Medel, A. Multielemental distribution patterns in premature human milk whey and pre-term formula milk whey by size exclusion chromatography coupled to inductively coupled plasma mass spectrometry with octopole reaction cell. J. Anal. At. Spectrom. 19, 1104-1110 (2004
36. Arosio, P., Ferrero, R. & Ponzone, A. Ferritin in human milk. Acta Paediatr. Scand. 73, 271-272 (1984
37. Lönnerdal, B. Bioactive proteins in breast milk. J. Paediatr. Child Health 49 (Suppl. 1), 1-7 (2013
38. Lönnerdal, B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am. J. Clin. Nutr. 99, 712S-717S (2014
39. Domellöf, M., Lönnerdal, B., Dewey, K. G., Cohen, R. J. & Hernell, O. Iron, zinc, and copper concentrations in breast milk are independent of maternal mineral status. Am. J. Clin. Nutr. 79, 111-115 (2004
40. Rai, D. et al. Longitudinal changes in lactoferrin concentrations in human milk: A global systematic review. Crit. Rev. Food Sci. Nutr. 54, 1539-1547 (2014
41. Davidsson, L., Kastenmayer, P., Yuen, M., Lönnerdal, B. O. & Hurrell, R. F. Influence of lactoferrin on iron absorption from human milk in infants. Pediatr. Res. 35, 117-124 (1994
42. Fairweather-Tait, S. J., Balmer, S. E., Scott, P. H. & Minski, M. J. Lactoferrin and iron absorption in newborn infants. Pediatr. Res. 22, 651-654 (1987
43. Stekel, A. et al. Absorption of fortification iron from milk formulas in infants. Am. J. Clin. Nutr. 43, 917-922 (1986
44. Abrams, S. A., Wen, J. & Stuff, J. E. Absorption of calcium, zinc, and iron from breast milk by five- to seven month old infants. Pediatr. Res. 41, 384-390 (1997
45. Mainous, A. G. 3rd, Wells, B., Carek, P. J., Gill, J. M. & Geesey, M. E. The mortality risk of elevated serum transferrin saturation and consumption of dietary iron. Ann. Fam. Med. 2, 139-144 (2004
46. Acikyol, B. et al. Brain transcriptome perturbations in the transferrin receptor 2 mutant mouse support the case for brain changes in iron loading disorders, including effects relating to long-term depression and long-term potentiation. Neuroscience 235, 119-128 (2013
47. Nandar, W. & Connor, J. R. HFE gene variants affect iron in the brain. J. Nutr. 141, 29S-739S (2011
48. Sobotka, T. J. et al. Neurobehavioral dysfunctions associated with dietary iron overload. Physiol. Behav. 59, 213-219 (1996)
49. Fredriksson, A., Schröder, N., Eriksson, P., Izquierdo, I. & Archer, T. Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol. Appl. Pharmacol. 159, 25-30 (1999
50. Piñero, D. J., Li, N. Q., Connor, J. R. & Beard, J. L. Variations in dietary iron alter brain iron metabolism in developing rats. J. Nutr. 130, 254-263 (2000
51. Dornelles, A. S. et al. mRNA expression of proteins involved in iron homeostasis in brain regions is altered by age and by iron overloading in the neonatal period. Neurochem. Res. 35, 564-571 (2010
52. Miwa, C. P. et al. Neonatal iron treatment increases apoptotic markers in hippocampal and cortical areas of adult rats. Neurotox. Res. 19, 527-535 (2011
53. Fernandez, L. L. et al. Early post-natal iron administration induces astroglial response in the brain of adult and aged rats. Neurotox. Res. 20, 193-199 (2011
54. Saarinen, U. M., Siimes, M. A. & Dallman, P. R. Iron absorption in infants: high bioavailability of breast milk iron as indicated by the extrinsic tag method of iron absorption and by the concentration of serum ferritin. J. Pediatr. 91, 36-39 (1977
55. Lönnerdal, B. & Bryant, A. Absorption of iron from recombinant human lactoferrin in young US women. Am. J. Clin. Nutr. 83, 305-309 (2006
56. Rao, R. et al. Iron supplementation dose for perinatal iron deficiency differentially alters the neurochemistry of the frontal cortex and hippocampus in adult rats. Pediatr. Res. 73, 31-37 (2013
57. Unger, E. L. et al. Behavior and monoamine deficits in prenatal and perinatal iron deficiency are not corrected by early postnatal moderate-iron or high-iron diets in rats. J. Nutr. 142, 2040-2049 (2012
58. Lugonja, N. et al. Differences in direct pharmacologic effects and antioxidative properties of mature breast milk and infant formulas. Nutrition 29, 431-435 (2013
59. Zecca, L., Youdim, M. B., Riederer, P., Connor, J. R. & Crichton, R. R. Iron, brain ageing and neurodegenerative disorders. Nat. Rev. Neurosci. 5, 863-873 (2004
60. Ghadery, C. et al. R2.mapping for brain iron: Associations with cognition in normal aging. Neurobiol. Aging 36, 925-932 (2015
61. Rodrigue, K. M., Haacke, E. M. & Raz, N. Differential effects of age and history of hypertension on regional brain volumes and iron. Neuroimage 54, 750-759 (2011
62. Callaghan, M. F. et al. Widespread age-related differences in the human brain microstructure revealed by quantitative magnetic resonance imaging. Neurobiol. Aging 35, 1862-1872 (2014
63. Ward, R. J., Zucca, F. A., Duyn, J. H., Crichton, R. R. & Zecca, L. The role of iron in brain ageing and neurodegenerative disorders. Lancet Neurol. 13, 1045-1060 (2014
64. Berg, D. & Youdim, M. B. Role of iron in neurodegenerative disorders. Top. Magn. Reson. Imaging 17, 5-17 (2006
65. Berg, D. et al. Brain iron pathways and their relevance to Parkinsons disease. J. Neurochem. 79, 225-236 (2001
66. Lhermitte, J., Kraus, W. M. & McAlpine, D. On the occurrence of abnormal deposits of iron in the brain in parkinsonism with special reference to its localisation. J. Neurol. Psychopathol. 5, 195-208 (1924
67. Sulzer, D. et al. Neuromelanin biosynthesis is driven by excess cytosolic catecholamines not accumulated by synaptic vesicles. Proc. Natl Acad. Sci. USA 97, 11869-11874 (2000
68. Zecca, L. et al. Substantia nigra neuromelanin: structure, synthesis, and molecular behaviour. Mol. Pathol. 54, 414-418 (2001
69. Bohic, S. et al. Intracellular chemical imaging of the developmental phases of human neuromelanin using synchrotron X ray microspectroscopy. Anal. Chem. 80, 9557-9566 (2008
70. Lei, P. et al. Tau deficiency induces parkinsonism with dementia by impairing APP-mediated iron export. Nat. Med. 18, 291-295 (2012
71. Ayton, S. et al. Ceruloplasmin dysfunction and therapeutic potential for Parkinson disease. Ann. Neurol. 73, 554-559 (2013
72. Jin, L. et al. Decreased serum ceruloplasmin levels characteristically aggravate nigral iron deposition in Parkinsons disease. Brain 134, 50-58 (2011
73. Wang, Z. et al. DJ 1 modulates the expression of Cu/Zn-superoxide dismutase 1 through the Erk1/2 Elk1 pathway in neuroprotection. Ann. Neurol. 70, 591-599 (2011
74. Rouault, T. A. Iron metabolism in the CNS: implications for neurodegenerative diseases. Nat. Rev. Neurosci. 14, 551-564 (2013
75. Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L. & Markesbery, W. R. Copper, iron and zinc in Alzheimers disease senile plaques. J. Neurol. Sci. 158, 47-52 (1998
76. Smith, M. A., Harris, P. L., Sayre, L. M. & Perry, G. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc. Natl Acad. Sci. USA 94, 9866-9868 (1997
77. Schrag, M., Mueller, C., Oyoyo, U., Smith, M. A. & Kirsch, W. M. Iron, zinc and copper in the Alzheimers disease brain: A quantitative meta-Analysis. Some insight on the influence of citation bias on scientific opinion. Prog. Neurobiol. 94, 296-306 (2011
78. Duce, J. A. et al. Iron-export ferroxidase activity of â-Amyloid precursor protein is inhibited by zinc in Alzheimers disease. Cell 142, 857-867 (2010
79. Smith, M. A. et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J. Alzheimers Dis. 19, 363-372 (2010
80. Antharam, V. et al. High field magnetic resonance microscopy of the human hippocampus in Alzheimers disease: quantitative imaging and correlation with iron. Neuroimage 59, 1249-1260 (2012
81. Raven, E. P., Lu, P. H., Tishler, T. A., Heydari, P. & Bartzokis, G. Increased iron levels and decreased tissue integrity in hippocampus of Alzheimer disease detected in vivo with magnetic resonance imaging. J. Alzheimers Dis. 37, 127-136 (2013
82. Hametner, S. et al. Iron and neurodegeneration in the multiple sclerosis brain. Ann. Neurol. 74, 848-861 (2013
83. Faux, N. G. et al. An anemia of Alzheimers disease. Mol. Psychiatr. 19, 1227-1234 (2014
84. Pichler, I. et al. Serum iron levels and the risk of parkinson disease: A Mendelian randomization study. PLoS Med. 10, e1001462 (2013
85. Ali-Rahmani, F., Schengrund, C. L. & Connor, J. R. HFE gene variants, iron, and lipids: A novel connection in Alzheimers disease. Front. Pharmacol. 5, 165 (2014
86. De Lau, L. M. & Breteler, M. M. Epidemiology of Parkinsons disease. Lancet Neurol. 5, 525-535 (2006
87. Zhu, X., Raina, A. K., Perry, G. & Smith, M. A. Alzheimers disease: the two-hit hypothesis. Lancet Neurol. 3, 219-226 (2004
88. Doraiswamy, P. M. & Finefrock, A. E. Metals in our minds: therapeutic implications for neurodegenerative disorders. Lancet Neurol. 3, 431-434 (2004
89. Devos, D. et al. Targeting chelatable iron as a therapeutic modality in Parkinsons disease. Antioxid. Redox Signal. 21, 195-210 (2014
90. Kaur, D. et al. Genetic or pharmacological iron chelation prevents MPTP-induced neurotoxicity in vivo: A novel therapy for Parkinsons disease. Neuron 37, 899-909 (2003
91. Kaur, D. et al. Increased murine neonatal iron intake results in Parkinson-like neurodegeneration with age. Neurobiol. Aging 28, 907-913 (2007
92. Fernandez, L. L. et al. Effects of increased iron intake during the neonatal period on the brain of adult AβPP/PS1 transgenic mice. J. Alzheimers Dis. 19, 1069-1080 (2010
93. Becerril-Ortega, J., Bordji, K., Frret, T., Rush, T. & Buisson, A. Iron overload accelerates neuronal amyloid-β production and cognitive impairment in transgenic mice model of Alzheimer disease. Neurobiol. Aging 35, 2288-2301 (2014
94. Erikson, K. M., Pinero, D. J., Connor, J. R. & Beard, J. L. Regional brain iron, ferritin and transferrin concentrations during iron deficiency and iron repletion in developing rats. J. Nutr. 127, 2030-2038 (1997
95. Powers, K. M. et al. Parkinsons disease risks associated with dietary iron, manganese, and other nutrient intakes. Neurology 60, 1761-1766 (2003
96. Benarroch, E. E. Brain iron homeostasis and neurodegenerative disease. Neurology 72, 1436-1440 (2009
97. Morris, C. M. et al. Brain iron homeostasis. J. Inorg. Biochem. 47, 257-265 (1992
98. Zecca, L. et al. The role of iron and copper molecules in the neuronal vulnerability of locus coeruleus and substantia nigra during aging. Proc. Natl Acad. Sci. USA 101, 9843-9848 (2004
99. Hare, D. J. et al. An iron-dopamine index predicts risk of parkinsonian neurodegeneration in the substantia nigra pars compacta. Chem. Sci. 5, 2160-2169 (2014
100. Hunt, J. R., Zito, C. A. & Johnson, L. K. Body iron excretion by healthy men and women. Am. J. Clin. Nutr. 89, 1792-1798 (2009
101. Arora, M. & Austin, C. Teeth as a biomarker of past chemical exposure. Curr. Opin. Pediatr. 25, 261-267 (2013
102. Hare, D., Austin, C., Doble, P. & Arora, M. Elemental bio-imaging of trace elements in teeth using laser ablation-inductively coupled plasma-mass spectrometry. J. Dent. 39, 397-403 (2011
103. Gunier, R. B. et al. Determinants of manganese in prenatal dentin of shed teeth from CHAMACOS children living in an agricultural community. Environ. Sci. Technol. 47, 11249-11257 (2013
104. Arora, M., Hare, D., Austin, C., Smith, D. R. & Doble, P. Spatial distribution of manganese in enamel and coronal dentine of human primary teeth. Sci. Total Environ. 409, 1315-1319 (2011
105. Austin, C. et al. Barium distributions in teeth reveal early-life dietary transitions in primates. Nature 498, 216-219 (2013
106. Bauminger, E., Ofer, S., Gedalia, I., Horowitz, G. & Mayer, I. Iron uptake by teeth and bones: A Mossbauer effect study. Calcif. Tissue Int. 37, 386-389 (1985
107. Garfunkel, A., Kantzuker, M., Gedalia, I. & Chevion, M. Iron concentration in teeth of patients with and without beta-thalassaemia major. Arch. Oral Biol. 24, 829-831 (1979
108. Ash, M. M. & Nelson, S. J. Wheelers Dental Anatomy, Physiology and Occlusion 8th edn (WB Saunders, 2003
109. Fildes, V. Breasts, Bottles and Babies-A History of Infant Feeding (Edinburgh University Press, 1986
110. Bermejo, P. et al. Speciation of iron in breast milk and infant formulas whey by size exclusion chromatography-high performance liquid chromatography and electrothermal atomic absorption spectrometry. Talanta 50, 1211-1222 (2000
111. Björklund, K. L. et al. Metals and trace element concentrations in breast milk of first time healthy mothers: A biological monitoring study. Environ. Health 11, 92 (2012
112. Ejezie, F. E., Nwagha, U. I., Ikekpeazu, E., Ozoemena, O. & Onwusi, E. Assessment of iron content of breast milk in preterm and term mothers in Enugu urban. Ann. Med. Health Sci. Res. 1, 85-90 (2011
113. Krachler, M., Prohaska, T., Koellensperger, G., Rossipal, E. & Stingeder, G. Concentrations of selected trace elements in human milk and in infant formulas determined by magnetic sector field inductively coupled plasma-mass spectrometry. Biol. Trace Elem. Res. 76, 97-112 (2000
114. Leotsinidis, M., Alexopoulos, A. & Kostopoulou-Farri, E. Toxic and essential trace elements in human milk from Greek lactating women: Association with dietary habits and other factors. Chemosphere 61, 238-247 (2005
115. Maru, M., Birhanu, T. & Tessema, D. A. Calcium, magnesium, iron, zinc and copper, compositions of human milk from populations with cereal and ensetbased diets. Ethiop. J. Health Sci. 23, 90-97 (2013
116. Mello-Neto, J. et al. Iron supplementation in pregnancy and breastfeeding and iron, copper and zinc status of lactating women from a human milk bank. J. Trop. Pediatr. 59, 140-144 (2013
117. Mello-Neto, J. et al. Iron concentrations in breast milk and selected maternal factors of human milk bank donors. J. Hum. Lact. 26, 175-179 (2010
118. World Health Organization & International Atomic Energy Agency. Minor and trace elements in breast milk: report of a joint WHO/IAEA collaborative study. World Health Organization Institutional Repository for Information Sharing [online], http://apps.who.int/iris/bitstream/10665/39678/1/9241561211.pdf?ua=1 (1989
119. Johnson, M. A., Smith, M. M. & Edmonds, J. T. Copper, iron, zinc, and manganese in dietary supplements, infant formulas, and ready to eat breakfast cereals. Am. J. Clin. Nutr. 67 (5 Suppl.), 1035S-1040S (1998
120. Ljung, K., Palm, B., Grandr, M. & Vahter, M. High concentrations of essential and toxic elements in infant formula and infant foods-A matter of concern. Food Chem. 127, 943-951 (2011
121. Saarinen, U. M. & Siimes, M. A. Iron absorption from infant milk formula and the optimal level of iron supplementation. Acta Paediatr. Scand. 66, 719-722 (1977
122. Walter, T., Pino, P., Pizarro, F. & Lozoff, B. Prevention of iron-deficiency anemia: comparison of high- and low-iron formulas in term healthy infants after six months of life. J. Pediatr. 132, 635-640 (1998
123. Chemizmu, K. & Fentona, R. Fenton reaction-controversy concerning the chemistry. Ecol. Chem. Eng. S. 16, 347-358 (2009
124. Bartzokis, G. et al. Brain ferritin iron may influence age- and gender-related risks of neurodegeneration. Neurobiol. Aging 28, 414-423 (2007
125. Schipper, H. M. Heme oxygenase 1: role in brain aging and neurodegeneration. Exp. Gerontol. 35, 821-830 (2000
126. Schipper, H. M. Brain iron deposition and the free radical-mitochondrial theory of ageing. Ageing Res. Rev. 3, 265-301 (2004
127. Chen, J. H., Singh, N., Tay, H. & Walczyk, T. Imbalance of iron influx and efflux causes brain iron accumulation over time in the healthy adult rat. Metallomics 6, 1417-1426 (2014
128. Kaplan, J. Strategy and tactics in the evolution of iron acquisition. Semin. Hematol. 39, 219-226 (2002
129. Quinn, E. A. Too much of a good thing: evolutionary perspectives on infant formula fortification in the United States and its effects on infant health. Am. J. Hum. Biol. 26, 10-17 (2014
130. Williams, R. J. Iron in evolution. FEBS Lett. 586, 479-484 (2012
131. Grandjean, P. & Landrigan, P. J. Neurobehavioural effects of developmental toxicity. Lancet Neurol. 13, 330-338 (2014
132. Engelhardt, B. & Liebner, S. Novel insights into the development and maintenance of the blood-brain barrier. Cell Tissue Res. 355, 687-699 (2014
133. Abbott, N. J., Patabendige, A. A., Dolman, D. E., Yusof, S. R. & Begley, D. J. Structure and function of the blood-brain barrier. Neurobiol. Dis. 37, 13-25 (2010
134. Jones, H. C., Keep, R. F. & Butt, A. M. The development of ion regulation at the blood-brain barrier. Prog. Brain Res. 91, 123-131 (1992
135. Xu, J. & Ling, E. A. Studies of the ultrastructure and permeability of the blood-brain barrier in the developing corpus callosum in postnatal rat brain using electron dense tracers. J. Anat. 184, 227-237 (1994
136. Morgan, E. H. & Moos, T. Mechanism and developmental changes in iron transport across the blood-brain barrier. Dev. Neurosci. 24, 106-113 (2002
137. Taylor, E. M. & Morgan, E. H. Developmental changes in transferrin and iron uptake by the brain in the rat. Brain Res. Dev. Brain. Res. 55, 35-42 (1990
138. Dani, C. et al. Effect of blood transfusions on oxidative stress in preterm infants. Arch. Dis. Child Fetal Neonatal Ed. 89, F408-F411 (2004
139. McCarthy, R. C. & Kosman, D. J. Iron transport across the blood-brain barrier: development, neurovascular regulation and cerebral amyloid angiopathy. Cell Mol. Life Sci. 72, 709-727 (2015
140. Wu, L. J. et al. Expression of the iron transporter ferroportin in synaptic vesicles and the blood-brain barrier. Brain Res. 1001, 108-117 (2004
141. Moos, T. & Rosengren Nielsen, T. Ferroportin in the postnatal rat brain: implications for axonal transport and neuronal export of iron. Semin. Pediatr. Neurol. 13, 149-157 (2006
142. Simpson, I. A. et al. A novel model for brain iron uptake: introducing the concept of regulation. J. Cereb. Blood Flow Metab. 35, 48-57 (2015
143. Bradbury, M. W. Transport of iron in the blood-brain-cerebrospinal fluid system. J. Neurochem. 69, 443-454 (1997
144. Moos, T. & Morgan, E. H. Kinetics and distribution of [59Fe-125I]transferrin injected into the ventricular system of the rat. Brain Res. 790, 115-128 (1998
145. Chen, J. H., Shahnavas, S., Singh, N., Ong, W. Y. & Walczyk, T. Stable iron isotope tracing reveals significant brain iron uptake in adult rats. Metallomics 5, 167-173 (2013
146. Maynard, C. J. et al. Overexpression of Alzheimers disease amyloid-β opposes the age-dependent elevations of brain copper and iron. J. Biol. Chem. 277, 44670-44676 (2002
147. Bilgic, B., Pfefferbaum, A., Rohlfing, T., Sullivan, E. V. & Adalsteinsson, E. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 59, 2625-2635 (2012